XTX Topco’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,509
| Closed | -$102K | – | 2375 |
|
|
2024
Q2 | $102K | Sell |
3,509
-2,027
| -37% | -$58.8K | 0.01% | 1416 |
|
|
2024
Q1 | $247K | Sell |
5,536
-2,234
| -29% | -$99.6K | 0.03% | 1007 |
|
|
2023
Q4 | $301K | Buy |
7,770
+2,034
| +35% | +$78.9K | 0.07% | 611 |
|
|
2023
Q3 | $169K | Buy |
+5,736
| New | +$169K | 0.03% | 1072 |
|
|
2023
Q2 | – | Sell |
-14,331
| Closed | -$676K | – | 1645 |
|
|
2023
Q1 | $676K | Buy |
14,331
+13,550
| +1,735% | +$640K | 0.14% | 154 |
|
|
2022
Q4 | $54.2K | Buy |
+781
| New | +$54.2K | 0.01% | 1039 |
|